Globus Medical, Inc. (GMED), Monday announced the resignation of Daniel Scavilla from the role of President and Chief Executive Officer effective July 18, 2025, to pursue another opportunity.
Following this, the company has appointed Keith Pfeil, Executive Vice President, Chief Operating Officer and Chief Financial Officer, as CEO.
Concurrently, the company announced preliminary results for the second quarter ending June 30, 2025, expecting sales of approximately $745.3 million, an as-reported increase of 18.4 percent over the second quarter of 2024.
Moreover, the company reaffirmed its full-year 2025 revenue guidance to be in the range of $2.80 to $2.90 billion, and non-GAAP earnings outlook to be in the range of $3.00 to $3.30 per share.
In the pre-market hours, GMED is trading at $55, down 2.33 percent on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.